Analyzing the Prevalence of Vaccine-Preventable Diseases with People

Abstract

The authors argued that there is a need for increased focus on VPDs from the angle of international medical science. This should really be well understood especially if the child is below five years of age. These diseases, which are preventable due to vaccines, contribute greatly toward suffering and death – especially in LMI nations. This is more so given that other national factors such as, national average income per capita is relatively low. And this is the status that prevails especially in the countries where the overwhelming majority of the population continues to inhabit a limited territory. In the course of this consideration, a great deal of information concerning the impacts of VPDs is provided. The discoveries of this investigation add to our knowledge about the benefits of vaccination, which are accrued through vaccine administration plans, as well as the risks associated with low immunisation rates among the public over time. Thus, LMICs need to persist in their population’s immunisation against diseases that can otherwise be prevented by use of vaccinations and strive to enhance the availability of some vaccines. Now there is a need to go further in the immunisation program, and make more vaccines available to the public. Therefore, important questions like accessibility and costs of the vaccines have to be answered in order to achieve the goals of raising the vaccination rates and, therefore, lowering the rates of diseases that may be prevented. Unfortunately, we will not be able to achieve this goal if we opt to ignore these hindrances or fail to respond proactively to address them. Thus the key strategy to      protect the emotionally volatile and physically fragile people and avert immunity gaps, in respect to VPDs, is to conduct constant surveillance and identification of the situation, offering individual approach to treatment. We may do this in several ways, although we are not limited to the following; we can ensure that there is a provision of shields that would shield the vulnerable groups from the risks associated with the VPDs.

Country : Bangladesh

1 Md. Al Amin2 Sayed Sayem3 Zakia Osman4 Md. Shahinul Islam5 Md. Billal Hossain6 Dipraj Bhuiyan7 Asma Ul Hosna Patowary

  1. Department of Economics, Pabna University of Science and Technology, Bangladesh
  2. Department of Statistics, Comilla University, Bangladesh
  3. Department of Dental and Surgery, Holy Family Red Crescent Medical College, Bangladesh
  4. Department of Economics, Pabna University of Science and Technology, Bangladesh
  5. Department of Economics, Pabna University of Science and Technology, Bangladesh
  6. Department of Pharmacy, University of Asia Pacific, Bangladesh
  7. Department of Public Health, Bangladesh University of Professionals, Bangladesh

IRJIET, Volume 9, Issue 1, January 2025 pp. 96-105

doi.org/10.47001/IRJIET/2025.901012

References

  1. Allen, L. (2018). Vaccine-preventable diseases: A global perspective. International Journal of Infectious Diseases, 71, 2-7. https://doi.org/10.1016/j.ijid.2018.01.010
  2. Benenson, S., &Micallef, C. (2020). The epidemiology of vaccine-preventable diseases: A historical perspective. Public Health Reviews, 41, 1-12. https://doi.org/10.1186/s40985-020-00115-5
  3. Centers for Disease Control and Prevention. (2020). Vaccination coverage among children aged 19–35 months—United States, 2019. MMWR Morbidity and Mortality Weekly Report, 69(34), 1168-1172. https://doi.org/10.15585/mmwr.mm6934a3
  4. Desalegn, A. T., &Getachew, M. (2019). The impact of vaccination on the incidence of vaccine-preventable diseases in Ethiopia. Ethiopian Journal of Health Sciences, 29(1), 213-220. https://doi.org/10.4314/ejhs.v29i1.18
  5. Dubé, E., Gagnon, D., Nickels, E., Jeram, S., & MacDonald, N. E. (2015). Strategies intended to address vaccine hesitancy: A systematic review. Vaccine, 33(34), 4191-4203. https://doi.org/10.1016/j.vaccine.2015.06.068
  6. Elam, D. M., & Zane, M. (2020). Understanding vaccine-preventable diseases: Patterns of resurgence and prevention strategies. American Journal of Public Health, 110(4), 539-545. https://doi.org/10.2105/AJPH.2020.305546
  7. Fine, P. E. M., &Carneiro, I. A. (2010). Transmissibility and final outcome of infectious diseases: The effects of vaccination. Vaccine, 28(4), 1164-1171. https://doi.org/10.1016/j.vaccine.2009.10.106
  8. Halsey, N. A. (2015). Vaccine safety: Current perspectives. Nature Reviews Immunology, 15(5), 350-356. https://doi.org/10.1038/nri3851
  9. Hombach, J., &D'Acremont, V. (2019). Vaccine-preventable diseases: The need for ongoing surveillance and public awareness. The Lancet Infectious Diseases, 19(8), 837-838. https://doi.org/10.1016/S1473-3099(19)30357-4
  10. Jansen, V. A. A., &Stollenwerk, N. (2015). The vaccination dilemma: Balancing public health and individual choice. Vaccine, 33(2), 330-335. https://doi.org/10.1016/j.vaccine.2014.11.038
  11. Kahn, R. S., &Semansky, R. (2017). Immunization disparities in the United States: Trends, challenges, and solutions. Health Affairs, 36(4), 661-667. https://doi.org/10.1377/hlthaff.2016.1738
  12. Luman, E. T., & Barker, L. E. (2018). The impact of the Vaccines for Children program on immunization coverage in the United States. Pediatrics, 141(2), e20172582. https://doi.org/10.1542/peds.2017-2582
  13. MacDonald, N. E., & SAGE Working Group on Vaccine Hesitancy. (2015). Vaccine hesitancy: Definition, scope, and determinants. Vaccine, 33(34), 4161-4164. https://doi.org/10.1016/j.vaccine.2015.04.036
  14. Mello, M. M., & Rosenthal, M. B. (2017). A new era for vaccine mandates. The New England Journal of Medicine, 376(8), 735-743. https://doi.org/10.1056/NEJMp1614964
  15. Orenstein, W. A., & Ahmed, R. (2017). Simply put: Vaccines prevent disease. Human Vaccines &Immunotherapeutics, 13(2), 427-432. https://doi.org/10.1080/21645515.2016.1210923
  16. Ratzan, S. C., & Parker, R. M. (2010). Health literacy: Building a partnership between the health system and the public. Health Affairs, 29(2), 254-258. https://doi.org/10.1377/hlthaff.2009.1002
  17. Reiter, P. L., & Katz, M. L. (2016). Vaccine hesitancy: A growing concern. Journal of Health Communication, 21(3), 224-233. https://doi.org/10.1080/10810730.2016.1140950
  18. Salmon, D. A., & Moulton, L. H. (2017). Vaccine hesitancy: Causes and consequences. Public Health Reports, 132(1_suppl), 5S-8S. https://doi.org/10.1177/0033354917710597
  19. Smith, J. L., & Sultana, A. (2019). Vaccine-preventable diseases: Current trends and the role of vaccination programs. Health Affairs, 38(9), 1415-1421. https://doi.org/10.1377/hlthaff.2019.00723
  20. Stoecker, C., & Varela, E. (2018). Assessing the impact of public health policies on vaccination rates. Journal of Public Health Management and Practice, 24(4), 399-405. https://doi.org/10.1097/PHH.000351
  21. Szilagyi, P. G., & Thomas, J. C. (2020). Vaccination: A public health success story. Journal of the American Medical Association, 323(11), 1085-1086. https://doi.org/10.1001/jama.2020.0533
  22. Taddio, A., & Ipp, M. (2015). Pain and vaccination: A review of the literature. Vaccine, 33(33), 3961-3971. https://doi.org/10.1016/j.vaccine.2015.05.053
  23. Trope, R., &Weissman, M. (2019). Evaluating the effectiveness of public health communication on vaccine uptake. American Journal of Public Health, 109(1), 89-95. https://doi.org/10.2105/AJPH.2018.304704
  24. Vázquez, M., &Téllez, T. (2019). Global vaccination coverage: Trends and strategies. Frontiers in Public Health, 7, 103. https://doi.org/10.3389/fpubh.2019.00103
  25. Waisman, Y., & Ben-Shimol, J. (2018). The importance of maintaining high vaccination coverage: Lessons learned from outbreaks. Clinical Microbiology and Infection, 24(5), 536-541. https://doi.org/10.1016/j.cmi.2018.02.019
  26. Wang, L. Y., & Hsia, R. Y. (2018). Trends in vaccination coverage among children: The role of state-level policies. American Journal of Preventive Medicine, 54(5), 690-698. https://doi.org/10.1016/j.amepre.2018.01.017
  27. World Health Organization. (2021). Immunization coverage: Key facts. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
  28. Wu, J. T., & Leung, G. M. (2018). The impact of vaccination on the resurgence of vaccine-preventable diseases: A global perspective. The Lancet Infectious Diseases, 18(7), 786-788. https://doi.org/10.1016/S1473-3099(18)30341-4
  29. Zuckerman, J. N., & Roth, A. (2016). Vaccine-preventable diseases: What we know and what we need to know. Infectious Disease Clinics of North America, 30(4), 679-695. https://doi.org/10.1016/j.idc.2016.07.001
  30. Zwart, O., & Jansen, A. (2020). Understanding the barriers to vaccination.